Peramivir

Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration

A Anant Labs fabrica e fornece impurezas de Peramivir de alta qualidade para o mercado global. Nossas impurezas EP de Peramivir são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.